Literature DB >> 8143860

A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase.

R Woscholski1, T Kodaki, M McKinnon, M D Waterfield, P J Parker.   

Abstract

The mammalian Ptdlns 3-kinase is shown to be inhibited by low nanomolar concentrations of demethoxyviridin, an antifungal agent structurally related to wortmannin. The inhibitory potency of both compounds could be observed in purified Ptdlns 3-kinase whether or not the regulatory subunit (p85 alpha) was present, suggesting that the inhibitors bind to the catalytic subunit (p110) of the Ptdlns 3-kinase. These inhibitors also show similar potency against the intrinsic p85-phosphorylating activity of the p110-kinase. However, the structurally related Ptdlns 3-kinase from Saccharomyces cerevisiae (Vps34p) is not inhibited by either compound. Both inhibitors target the mammalian Ptdlns 3-kinase in vitro and in vivo, implying that these compounds should be useful in suppressing Ptdlns 3-kinase in mammalian systems. The inhibitors did not affect the mammalian Ptdlns 4-kinase, but they are able to inhibit a membrane-associated Ptdlns 4-kinase from Schizosaccharomyces pombe.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143860     DOI: 10.1016/0014-5793(94)80482-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Overexpression of a rat kinase-deficient phosphoinositide 3-kinase, Vps34p, inhibits cathepsin D maturation.

Authors:  P E Row; B J Reaves; J Domin; J P Luzio; H W Davidson
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

2.  Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.

Authors:  B Vanhaesebroeck; K Higashi; C Raven; M Welham; S Anderson; P Brennan; S G Ward; M D Waterfield
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

3.  Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

Authors:  T Skorski; A Bellacosa; M Nieborowska-Skorska; M Majewski; R Martinez; J K Choi; R Trotta; P Wlodarski; D Perrotti; T O Chan; M A Wasik; P N Tsichlis; B Calabretta
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

4.  Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.

Authors:  M P Wymann; G Bulgarelli-Leva; M J Zvelebil; L Pirola; B Vanhaesebroeck; M D Waterfield; G Panayotou
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  N-Methyl-4-hydroxy-2-pyridinone analogues from Fusarium oxysporum.

Authors:  Lalith Jayasinghe; Hamed K Abbas; Melissa R Jacob; Wimal H M W Herath; N P Dhammika Nanayakkara
Journal:  J Nat Prod       Date:  2006-03       Impact factor: 4.050

6.  Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.

Authors:  W G King; M D Mattaliano; T O Chan; P N Tsichlis; J S Brugge
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  Evaluating PI3 kinase isoforms using Transcreener ADP assays.

Authors:  Tony A Klink; Karen M Kleman-Leyer; Andrew Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  J Biomol Screen       Date:  2008-06-19

8.  Novel regulation of aquaporins during osmotic stress.

Authors:  Rosario Vera-Estrella; Bronwyn J Barkla; Hans J Bohnert; Omar Pantoja
Journal:  Plant Physiol       Date:  2004-08-06       Impact factor: 8.340

9.  Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.

Authors:  Shannon McNulty; William Bornmann; Jill Schriewer; Chas Werner; Scott K Smith; Victoria A Olson; Inger K Damon; R Mark Buller; John Heuser; Daniel Kalman
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

10.  Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade.

Authors:  Jae Youl Cho; Jongsun Park
Journal:  Int J Mol Sci       Date:  2008-11-12       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.